MedPath

Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection

Terminated
Conditions
COVID-19
Pulmonary Infection
Pneumonia, Viral
Interventions
Diagnostic Test: Lung ultrasound
Registration Number
NCT04422691
Lead Sponsor
St. Olavs Hospital
Brief Summary

In light of the ongoing COVID-19 epidemic in Norway, it is paramount to develop and utilize clinical tools for assessing and risk stratifying patients with suspected coronary infection in the emergency departments. Diagnostic use of ultrasound in viral pneumonias, including COVID-19 has proved to be very useful. The use of ultrasound will assist in quick detection of lung pathology compatible with increasing severity of the COVID-19 disease. At the same time, the use of ultrasound diagnostics in the emergency department could improve logistics and reduce potential exposure of the corona virus to other health personnel.

The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • All emergency department patients with suspected or diagnosed COVID-19.
Exclusion Criteria
  • Negative screening for COVID-19
  • recent negative COVID-19 test
  • no indication for isolation in the Emergency Department

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Covid-19 suspectedLung ultrasoundEmergency department patients with suspected or diagnosed COVID-19 disease. All patients will be screened at triage and put into isolation if suspected disease. Ultrasound of the patients lungs will be performed after patient consent and findings will be recorded and categorized (Soldati et al., 2020). The use of ultrasound and registration of data will not affect the regular patient evaluation, treatment or logistics.
Primary Outcome Measures
NameTimeMethod
Level-of-careup to 7 days

In-hospital treatment level, e.g. discharge from ED, observational unit, ward, ICU.

Mortalityup to 30 days

30-day mortality

Secondary Outcome Measures
NameTimeMethod
Oxygen usage in the emergency departmentWithin 24 hours
Emergency department length of stayWithin 24 hours

in hours

In-hospital length of stayUp to 30 days

in days

Antibiotics usageWithin 24 hours

Trial Locations

Locations (9)

Sørlandet sykehus, Kristiansand

🇳🇴

Kristiansand, Norway

Ullevål University Hospital

🇳🇴

Oslo, Norway

Sykehuset Telemark HF

🇳🇴

Skien, Norway

St Olavs Hospital

🇳🇴

Trondheim, Norway

Nordland Hospital

🇳🇴

Bodø, Norway

Akershus University Hospital

🇳🇴

Oslo, Norway

Stavanger Universitetssjukehus

🇳🇴

Stavanger, Norway

Drammen sykehus

🇳🇴

Drammen, Norway

Haukeland universitetssykehus

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath